Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if a program of intensive chemotherapy with
gemcitabine, docetaxel and capecitabine followed by an advanced form of focused radiation
aimed at the patient's tumor followed by more chemotherapy can increase the chances that the
patient's pancreatic tumor can be removed completely.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute